or
forgot password
  • cancer clinical trials in east syracuse, NY

  • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Melanoma (Skin)
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer
    Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Infection, Multiple Myeloma and Plasma Cell Neoplasm
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Lymphoma
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer
    Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Leukemia
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Lung Cancer
    Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Prostate Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Esophageal Cancer, Gastric Cancer
    Buspirone in Reducing Shortness of Breath in Patients With Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Dyspnea, Pulmonary Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Metastatic Cancer, Prostate Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Colorectal Cancer
    Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma
    Hematology Oncology Associates of Central New York, PC - Northeast Center
    East Syracuse, New York 13057-4510
    Lymphoma
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer
    Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Lymphoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Metastatic Cancer, Prostate Cancer
    Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Lymphoma
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Head and Neck Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Osteoporosis, Prostate Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Prostate Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Esophageal Cancer
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer
    Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Anal Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Neurotoxicity, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Granisetron, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron in Preventing Nausea in Patients Undergoing Chemotherapy for Breast Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer, Nausea and Vomiting
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
    Hematology Oncology Associates of New York
    East Syracuse, New York 13057
    Breast Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Leukemia
    Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Lymphoma
    Safety Study of TAK-700 in Subjects With Prostate Cancer.
    Hematology/Oncology Associates of Central New York
    East Syracuse, New York
    Prostatic Neoplasms
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Colorectal Cancer
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Musculoskeletal Complications, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Brain and Central Nervous System Tumors
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Lung Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Lung Cancer
    Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Leukemia
    Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Leukemia
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Colorectal Cancer, Precancerous Condition
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Hematology Oncology Associates of Central New York PC
    East Syracuse, New York 13057
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Malignant Mesothelioma
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    CCOP - Hematology-Oncology Associates of Central New York
    East Syracuse, New York 13057
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity